p53AIP1, a Potential Mediator of p53-Dependent Apoptosis, and Its Regulation by Ser-46-Phosphorylated p53  by Oda, Katsutoshi et al.
Cell, Vol. 102, 849–862, September 15, 2000, Copyright ª 2000 by Cell Press
p53AIP1, a Potential Mediator
of p53-Dependent Apoptosis, and Its
Regulation by Ser-46-Phosphorylated p53
shock, hypoxia, osmotic shock, and DNA damage,
which in turn leads to growth arrest and/or apoptosis
(Oren, 1994; Ko and Prives, 1996; Levine, 1997 for re-
view). However, it is still largely unknown how p53 se-
lects the pathways of G1-arrest or apoptosis. In this
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context, the proline-rich domain (residues 64–92; Walkerand Yoichi Taya2,3,6
and Levine, 1996; Venot et al., 1998) and a recently1 Laboratory of Molecular Medicine
identified transcriptional activation domain (residuesHuman Genome Center
43–63; Zhu et al., 1998) of p53 have each been suggested
Institute of Medical Science to be necessary for mediation of apoptosis because
University of Tokyo deletion of either of these two domains abolishes this
4-6-1 Shirokanedai, Minato-ku activity. On the other hand, it has been shown that phos-
Tokyo 108-8639 phorylation and acetylation play important roles for reg-
Japan ulating biological activities of p53 (Giaccia and Kastan,
2 Biology Division 1998; Prives, 1998). Indeed, phosphorylation of p53 at
National Cancer Center Research Institute Ser-15 and Ser-20 has been shown to be involved in
5-1-1 Tsukiji, Chuo-ku activating p53 (Shieh et al., 1997; Siliciano et al., 1997;
Chehab et al., 2000; Shieh et al., 2000). Although theTokyo 104-0045
roles of these modifications are not fully characterized,Japan
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Upon examination of the amino acid sequence of1063-103 Ohara
these proapoptotic N-terminal regions of p53, we notedTerasawaoka, Ina
a number of potential in vivo phosphorylation sites in-Nagano 396-0002
cluding Ser-46. Because Ser-46 is followed by Pro-47,Japan
it could be phosphorylated by members of cyclin-depen-5 Department of Molecular Biology dent kinase or MAP kinase families in vivo. Whereas we
Cancer Research institute do not yet entirely understand how p53 exerts its effect
Sapporo Medical College on cells, it is clear that the transcriptional activating
16 Minami-ichijo-nishi, Chuo-ku function of p53 is a major component of its biological
Sapporo 060-8648 effects, including cell cycle arrest and apoptosis. Actu-
Japan ally, many p53 target genes have been identified and those
functions have been characterized. It is well known that
p53-dependent cell cycle arrest requires transactivation
of p21Waf1, which inhibits the cyclin-dependent kinasesSummary
(reviewed in Ko and Prives, 1996). p53R2, which is the
ribonucleotide reductase gene, has been isolated andThrough direct cloning of p53 binding sequences from
shown to play a crucial role for DNA repair by p53 afterhuman genomic DNA, we have isolated a novel gene,
DNA damage (Tanaka et al., 2000). As candidates todesignated p53AIP1 (p53-regulated Apoptosis-Induc-
mediate p53-dependent apoptosis, several p53 targeting Protein 1), whose expression is inducible by wild- genes including Bax and PIG genes have been sug-
type p53. Ectopically expressed p53AIP1, which is lo- gested (Miyashita and Reed, 1995; Polyak et al., 1997).
calized within mitochondria, leads to apoptotic cell However, many putative apoptosis-inducing p53 target
death through dissipation of mitochondrial DCm. We genes do not induce apoptosis when expressed alone
have found that upon severe DNA damage, Ser-46 on (Polyak et al., 1997).
p53 is phosphorylated and apoptosis is induced. In We have been attempting to isolate novel p53 target
addition, substitution of Ser-46 inhibits the ability of genes by two different strategies. One is a differential
display method using a cell line in which the expressionp53 to induce apoptosis and selectively blocks expres-
of an exogenous wild-type p53 gene can be regulatedsion of p53AIP1. Our results suggest that p53AIP1 is
under the control of the lactose operon (Takei et al.,likely to play an important role in mediating p53-depen-
1998). By this approach, we previously isolated threedent apoptosis, and phosphorylation of Ser-46 regu-
novel p53-inducible genes, TP53TG1, TP53TG3, andlates the transcriptional activation of this apoptosis-
p53R2 (Takei et al., 1998; Ng et al., 1999; Tanaka etinducing gene.
al., 2000). The other approach is a yeast enhancer trap
system that allows direct cloning of p53 binding se-
Introduction quences from human genomic DNA (Tokino et al., 1994).
We isolated cosmid clones containing “functional” p53
The p53 tumor suppressor protein is stabilized and acti- binding sites and screened candidate genes in the vicin-
vated by a variety of cellular stresses such as heat ity of those sites. In this manner, we have isolated sev-
eral additional p53 target genes, such as GML (Furuhata
et al., 1996), P2XM (Urano et al., 1997), BAI1 (Nishimori6 To whom correspondence should be addressed (e-mail: ytaya@
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Figure 1. Identification of the p53AIP1 Gene
(A) Induction of p53AIP1 by p53. A Northern
blot was prepared using 3 mg of poly(A)1 RNA
isolated from U373MG cells infected with Ad-
p53 for 48 hr. Autographs of the Northern blot
performed with p53AIP1 and b-actin probes
are shown.
(B) Predicted amino acid sequences of
p53AIP1a, b, and g. Black background indi-
cates amino acid identity. (DDBJ EMBL/
GenBank accession number is AB045830–
AB045832.)
(C) Genomic structure of p53AIP1. Exon-
intron organization and alternative transcripts
of the p53AIP1 gene are presented. A poten-
tial p53 binding site (p53-BDS) is identified
in intron 1. Comparison of sequences of a
potential p53 binding site to the consensus
sequence. Nucleotides in capital letters rep-
resent identity of a genomic sequence to the
consensus, whereas lower case letters iden-
tify disparities with the consensus. R, purine;
Y, pyrimidine; W, A or T.
(D) EMSA. In the designated lanes, the p53
antibodies pAb421 and pAb1801 were in-
cluded. The p53 and DNA interaction was in-
hibited by unlabeled oligonucleotides corre-
sponding to the binding site of the p53AIP1
gene (Self) but not by the nonspecific oligonu-
cleotides (TL).
(E) p53 responsiveness of p53BDS. Reporters
containing either one [p53BDS(13)] or two
copies [p53BDS(23)] of the p53BDS se-
quences or 500 bp genomic sequence in in-
tron 1 (intron 1-wt or intron 1-mt) containing
p53BDS were constructed. A point mutation
of the fourth nucleotide C to T of p53BDS
was inserted into 500 bp genomic sequence
(intron 1-mt). Activity is represented as a rela-
tive value of measured luminescence from
firefly luciferase versus Renilla luciferase
from cotransfected pRL-TK (internal control).
Mean values of the results of three experi-
ments are displayed with error bars of stan-
dard deviations.
p53AIP1, which is involved in the p53-dependent apo- not shown). The entire 40 kb genomic sequence con-
tained in cos38 was determined by shot-gun sequenc-ptosis pathway. Moreover, we provide evidence that
Ser-46 of p53 is phosphorylated in response to DNA ing. Analysis with the GRAIL2 computer program (Solov-
yev et al., 1994) predicted 12 possible exons withdamage in vivo, and it plays a pivotal role for apoptotic
signaling by p53 through regulating the transcriptional “excellent” or “good” scores; the GENSCAN program
(Burge and Karlin, 1997) also predicted 12 possible ex-activation of an apoptosis-inducing gene, p53AIP1.
ons. Among them, four were predicted as candidate
exons by both programs; hence, a total of 20 candidate
exonic segments were present in the vicinity of putativeResults
p53 binding sequences. We synthesized oligonucleotides
corresponding to the candidate exons and performedIsolation of a Novel p53-Inducible
exon connection experiments, using cDNA reverse tran-Transcription Unit
scribed from thymus mRNA. This effort produced a 474Using a yeast enhancer trap system, we isolated a num-
bp cDNA fragment consisting of the two predicted exonsber of human genomic sequences that appear to acti-
(data not shown).vate transcription in a p53-dependent manner (p53-
tagged sites; Tokino et al., 1994). A 190 bp DNA fragment
corresponding to one of those sites (clone TP53-41) was Isolation of the p53AIP1 Gene
sequenced and found to contain a putative p53 binding To isolate a full-length cDNA of the gene represented by
sequence (BDS; Figure 1C). To isolate a larger genomic the exon-connected fragment, U373MG (glioblastoma)
region including this fragment, we screened a human cells were infected for 48 hr with a replication-defective
cosmid library using clone TP53-41 as a probe and iso- adenovirus engineered to express wild-type p53 (Ad-
lated a cosmid-designated TP53-cos38, which we p53), and polyA RNA was isolated from the cells. North-
ern blot analysis using the 474 bp cDNA fragment as amapped to chromosome 11q24 by FISH analysis (data
Apoptosis Regulation by p53AIP1 and Ser-46 of p53
851
probe (Figure 1A) detected 0.8 kb and 2.7 kb transcripts Subcellular Localization of p53AIP1
that were strongly induced in the U373MG cells by infec- The PSORT motif prediction program (Nakai and Kane-
tion with Ad-p53. However, Northern blotting analysis hisa, 1992) indicated the presence of a potential mito-
using mRNAs from 16 normal human tissues revealed chondrial targeting sequence at the N termini of
expression of the gene only in thymus (data not shown). p53AIP1a and p53AIP1b, suggesting that p53AIP1 might
We constructed a cDNA library using the poly(A)1 RNA be a mitochondrial protein. We constructed a plasmid
from transfected U373MG cells, screened this library clone, pCAGGS/C-HA-p53AIP1a, that was designed to
using the exon-connected fragment as a probe, and express p53AIP1a with an HA tag at the C-terminal end.
obtained 20 positive clones. Sequencing of these cDNA We transfected this plasmid DNA into COS-7 cells and
clones identified three major transcripts, designated a, detected the tagged proteins by immunofluorescent
b, and g, which consisted respectively of 806, 777, and staining. As shown in Figure 2A, p53AIP1a was strongly
2659 nucleotides with open reading frames encoding stained in the perinuclear region and appeared as a
124, 86, and 108 amino acids (Figure 1B). Computer dotted pattern in cytoplasm. When we stained mito-
analysis using the FASTA (Pearson, 1990) and BLAST chondria using an anti-mitochondrial antibody, the
programs (Altschul et al., 1990) detected no significant green signal of p53AIP1 coincided exactly with the red
homology between these three products and any known one of mitochondria, confirming a mitochondrial loca-
protein in the public database. A comparison of genomic tion of p53AIP1 protein. Mitochondrial localization of
and cDNA sequences defined the genomic structure of endogenous p53AIP1 after irradiation of gamma ray was
this novel gene, which we designated p53AIP1 on the also confirmed using anti-p53AIP1 antibody in MCF-7
basis of the functional characteristics described below. cells (Figure 2B).
The gene spans an 8.2 kb genomic region and consists
of five exons (Figure 1C). The three transcripts are gener- Induction of Endogenous p53AIP1 by DNA Damage
ated by alternative splicing; exon 2 of p53AIP1g includes Since p53AIP1 is responsive to wild-type p53, we exam-
introns 2 and 3 of p53AIP1a. The original 190 bp genomic ined whether its expression could be induced after g
fragment containing a potential p53 binding site (TP53- irradiation or exposure to adriamycin in either the NHDF
41) was found to lie within intron 1. cell line, which contains wild-type p53, or SW480, which
does not. DNA damage from either genotoxic agent
p53AIP1 as a Novel Target for p53 strongly induced transcription of p53AIP1 in NHDF cells
We performed electromobility shift assays (EMSA) to but not in SW480 cells (Figure 2C). While p21Waf1 expres-
test whether p53 was able to bind to oligonucleotides sion in NHDF cells reached a maximum after 6 hr of
corresponding to the p53BDS sequence in intron 1 of exposure to either adriamycin or ionizing radiation, max-
the p53AIP1 gene. As shown in Figure 1D, the site bound imum levels of p53AIP1 were observed only after 24 hr
a molecule in nuclear extracts of H1299 (lung carcinoma) of exposure. These results suggest that although
cells infected with Ad-p53. When we added anti-p53 p53AIP1 is induced in response to DNA damage, its
antibodies (PAb421 and/or PAb1801) to the mixture, ad- induction is likely to be quite different from that of
ditional shifted bands were observed. Unlabeled self- p21Waf1.
oligonucleotide but not a random oligonucleotide inhib-
ited these interactions. The results suggested that p53
p53AIP1 Induces Apoptosis through Dissipationprotein could in fact bind to p53BDS in vitro. To fur-
of Mitochondrial DCmther evaluate the transcription-enhancing activity of
We performed colony formation assays to investigatethe binding sequences, we performed a reporter assay
whether p53AIP1 itself functions as growth suppres-with the heterologous luciferase gene fused to one
sor. After constructing mammalian expression vectors[p53BDS(13)] or two copies [p53BDS(23)] of p53BDS
(pCAGGS/N-HA-p53AIP1a, b, and g) containing the en-upstream of the SV40 promoter (SV40-BDS) of the
tire coding sequence of each transcript, we confirmedpGL3 promoter vector. Transfection of p53BDS(13),
by immunoblotting that each was expressed in mamma-p53BDS(23), or control (SV40 promoter without a p53
lian cells, using rat anti-HA tag monoclonal antibodybinding site) vector into colon cancer cells (SW480) lack-
(3F10, Boehringer; data not shown). To confer geneticining wild-type p53 did not enhance luciferase activity.
resistance, the pcDNA3.1(1) vector was cotransfectedHowever, cotransfection of p53BDS(13) or p53BDS(2x)
into T98G (glioblastoma) cells with the p53AIP1a, b, orwith the wild-type p53 (wt-p53) expression plasmid in-
g expression plasmids. Transfected cells were grown increased luciferase activity significantly, while cotrans-
the presence of geneticin for 2 weeks. Figure 3A showsfection with mutant p53 (mt-p53) failed to do so (Figure
that introduction of pCAGGS/N-HA-p53AIP1a or b re-1E). Heterogeneous reporter vectors (intron 1-wt or in-
sulted in substantial growth suppression, as seen by atron 1-mt) were constructed by cloning a 500 bp seg-
3- to 4-fold decrease in the number of geneticin-resis-ment corresponding to intron 1 of the p53AIP1 gene
tant colonies. Growth suppression was also observed(intron 1-wt), or the same 500 bp segment (intron 1-mt)
when HA tag was inserted into the C terminus of thecontaining a mutated p53BDS sequence, upstream of
pCAGGS vector (pCAGGS/C-HA-p53AIP1a or b; datathe SV40 minimal promoter, respectively. Intron 1-wt or
not shown). Although we tried to establish a stable trans-intron 1-mt reporter vectors were cotransfected into the
formant that would overexpress p53AIP1, we were un-SW480 cell line, along with either wt-p53 or mt-p53 ex-
successful, most likely because of the cytotoxity ob-pression vectors. Luciferase activity of intron 1-wt but
served in the colony formation assays.not intron 1-mt was increased by cotransfection of the
Its late induction by p53, its growth-suppressing activ-wt-p53 expression vector (Figure 1E), while mt-p53 did
ity, and its mitochondrial localization prompted us tonot enhance the activity of intron 1-wt reporter vector
speculate that p53AIP1 might play an important role in(Figure 1E). Thus, the binding site we identified serves
p53-dependent apoptosis. We performed TUNEL analy-as a p53 response element, leading to the conclusion
that p53AIP1 is a bona fide direct target of p53. sis to investigate whether introduction of exogenous
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Figure 2. Expression of p53AIP1
(A) Localization of p53AIP1a in COS-7 cells.
COS-7 cells were transfected with plasmid
DNA designed to express HA-tagged p53AIP1a
(pCAGGS/N-HA-p53AIP1a). Cells were dou-
ble stained with anti-HA antibody (FITC) and
anti-human mitchondria antibody (Rhoda-
mine).
(B) Mitochondrial localization of endogenous
p53AIP1. MCF-7 cells were irradiated with g
ray (30 Gy) and stained with anti-p53AIP1 an-
tibody (FITC) and anti-human mitchondria an-
tibody (Rhodamine) after 48 hr.
(C) Induction of endogenous p53AIP1 mRNA
by DNA damages in human cells.
Results of RT–PCR experiments following ge-
notoxic stresses are shown. Expression of
the GAPDH gene was examined as a quantity
control. Induction of p53AIP, and p21/WAF1
expression following g radiation and adriamy-
cin treatment. NHDF, a normal human dermal
fibroblast cell line containing the wild-type
p53 gene. SW480, a colorectal adenocarci-
noma cell line lacking the wild-type p53 gene.
p53AIP1 could actually induce apoptotic cell death. We An FITC-labeled control oligonucleotide transfected
with lipofectin was incorporated into nuclei of .90%transfected the HA-tagged p53AIP1a expression vector
into T98G cells and harvested the cells after 48 hr. U373MG cells within 4 hr of transfection (data not
shown). Pretreatment of U373MG cells with AS1 but notTUNEL analysis showed that more than half of the T98G
cells expressing p53AIP1a underwent apoptosis. As SE1 strikingly inhibited induction of p53AIP1 expression
(Figure 4C) as well as induction of p53-inducing apo-controls, we also transfected a wild-type p53 or mutant
p53 (p53-R273H) expression vector into T98G cells. In- ptosis (Figure 4D). These results indicate that p53AIP1
is likely be an important and indispensable mediator oftroduction of ectopic wild-type p53 also caused apo-
ptotic cell death, whereas TUNEL-positive cells were p53-dependent apoptosis.
significantly fewer in cultures that were transfected with
the plasmid DNA designed to express mutant p53 (Fig-
ure 3B). Transfection of pCAGGS vector alone did not Phosphorylation of Ser-46 Is Closely Correlated
with Apoptosis Inductioninduce apoptotic cell death (data not shown).
To investigate the mechanism by which p53AIP1 in- As described in the Introduction, Ser-46 is a phosphory-
lation site that may regulate the apotosis-inducing abilityduces apoptosis, we examined the mitochondrial DCm,
an indicator of electrochemical gradient across the mito- of p53. Thus, we generated antibodies to specifically
recognize phospho-Ser-46. We first investigated phos-chondrial inner membrane, using Mito-tracker CMXRos
(Molecular Probes). Almost all cells expressing p53AIP1a phorylation of several different sites on p53 after treat-
ment of MCF7 cells with different DNA damaging agents,revealed dissipation of mitochondrial DCm at 24 hr after
transfection (Figure 3C). including ultraviolet (UV) radiation, g irradiation (IR), and
adriamycin treatment (ADR). We chose 30 J/m2 of UVTo investigate the in vivo effect of p53AIP1, adenovi-
rus vectors expressing p53AIP1a and b, or a control Ad- radiation, 30 Gy of IR, and 3 mM of ADR, which were
each high enough to induce apoptosis in MCF-7 cellsLacZ vector, were constructed and used to infect T98G
cells. FACS and TUNEL assays performed at 72 hr after (data not shown). Antibodies that recognize p53 phos-
phorylated at Ser-15, Ser-20, and Ser-46 were used toinfection clearly indicated induction of apoptosis by Ad-
p53AIP1a and b, but not Ad-LacZ, (Figure 4A). Moreover, detect modified p53 before and after such treatments
(Figure 5). After UV irradiation, phosphorylation of Ser-apoptotic cell death was induced by Ad-p53AIP1a in a
dose-dependent manner (Figure 4B). We also examined 15 and Ser-20 was detected at 1–2 hr, almost at the
same time as p53 accumulation, reaching a maximumwhether inhibition of endogenous p53AIP1 could block
p53-dependent apoptosis induced by infection of Ad- at 12 hr and then decreasing (Figure 5A). In contrast,
initiation of phosphorylation of Ser-46 was significantlyp53. To inhibit p53AIP1 expression, we established
sense (SE1) and antisense (AS1) oligonucleotides corre- delayed compared to Ser-15 and Ser-20, though it
reached a peak at 12 hr (Figure 5A). A similar delay ofsponding to part of the p53AIP1 cDNA sequence.
Apoptosis Regulation by p53AIP1 and Ser-46 of p53
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Figure 4. p53AIP1 Mediate p53-Inducing Apoptosis
(A) Ad-p53AIP1a and b but not Ad-LacZ induce apoptosis in T98G
cells. In T98G cells infected by Ad-p53AIP1a, b, or Ad-LacZ, apo-
ptotic cells were evaluated by FACS and TUNEL analyses at 72 hrFigure 3. Induction of Apoptosis by Ectopic Expression of p53AIP1
after infection.(A) Growth suppression of T98G by ectopic p53AIP1 expression.
(B) Apoptosis of T98G cells was induced by infection of Ad-HA-tagged p53AIP1a, b, and g (pCAGGS/N-HA-p53AIP1-a, b, and
p53AIP1a in a dose-dependent manner. In T98G cells infected byg) expression vector and mock vector (pCAGGS) were cotransfected
various doses of Ad-p53AIP1a, apoptotic cells were evaluated bywith pcDNA3.1(1) vector into T98G cells and cultured in presence
FACS analysis at 72 hr after infection.of 600 mg/ml of geneticin for 2 weeks.
(C) Inhibition of p53AIP1a mRNA expression by antisense oligonu-(B) Induction of apoptosis by ectopic expression of p53AIP1a. T98G
cleotide. Antisense oligonucleotides (AS) or sense oligonucleotidescells were transfected with either pCAGGS/N-HA-p53AIP1a, the
(SE) (1 mM) were transfected to U373MG cells with Lipofectin reagentwild-type p53, and the mutatnt (R273H) p53 expression vector. Ex-
(GIBCO–BRL) for 4 hr, and then cells were infected with Ad-p53.pression of p53AIP1a or the wild-type and mutant p53 were detected
Forty-eight hours after infection, RNA were isolated, cDNAs wereby anti-HA antibody or anti-p53 antibody, respectively. Apoptosis
synthesized, and p53AIP1a expression was examined by RT–PCR.was detected by TUNEL method with FITC emission.
(D) Inhibition of p53AIP1a expression block p53-depedent apo-(C) p53AIP1a induces dissipation of mitochondrial DCm. Upper left,
ptosis. Antisense oligonucleotides (AS) or sense oligonucleotidesexpression of p53AIP1a was detected by anti-HA antibody (green).
(SE) (1 mM) were transfected to U373MG cells with Lipofectin reagentUpper right, mitochondrial DCm was stained by MitoTracker Red
(GIBCO–BRL) for 4 hr, and then cells were infected with variousCMXRos (red). Lower left, overlay image of ectopic expressed p53
doses of Ad-p53. Forty-eight hours after infection, apoptotic cellsAIP1a protein and mitochondrial DCm. Lower right, overlay image
were evaluated by FACS analysis.of DAPI and mitochondrial DCm.
We compared the dose-dependent effects of UV radi-
ation on site-specific phosphorylation of p53 and apo-initiation of Ser-46 was also observed after IR and ADR
(Figures 5B and 5C). To examine whether this novel ptosis in MCF-7 cells. UV radiation stimulated the accu-
mulation of p53 from 10–15 J/m2. While phosphorylationphosphorylation of p53 at Ser-46 is cell line–specific,
we used TIG-7 cells (human fibroblast) and A549 cells of both Ser-15 and Ser-20 was detected from 10–15
J/m2, phosphorylation of Ser-46 was detected only at(human lung cancer), which express wild-type p53. As
with MCF7 cells, a similar delayed pattern of Ser-46 20 J/m2 (Figure 5D). The effect of UV radiation on the
cell cycle distribution of MCF-7 cells was examined byphosphorylation was also observed in these cell lines
(data not shown). FACS analysis. UV radiation increased the number of
Cell
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Figure 5. Phosphorylation of Ser-46 Is Correlated with Apoptosis Induction
Ser-46, a novel phosphorylation site of p53, is phosphorylated after DNA damage in a time-dependent manner, and dose dependency of Ser-
46-phosphorylation of p53, p53AIP1 induction, and apoptosis are closely correlated in UV radiation of MCF-7 cells. Time course of p53
expression and phosphorylation at Ser-15, Ser-20, and Ser-46 in MCF-7 cells after UV radiation (UV) (A), g irradiation (IR) (B), and treatment
with adriamycin (ADR) (C).
(D) Expression and phosphorylation of p53 at Ser-15, Ser-20, and Ser-46 after UV radiation. Cell lysates were analyzed by immunoblotting
using specific antibodies at 12 hr after UV radiation.
(E) FACS analysis at 36 hr after UV radiation. The percentage of population in the G0/G1 phase is presented as representative data.
(F) Apoptosis analyzed by TUNEL assay and DNA ladder assay at 48 hr after UV radiation. The upper panel shows the percentage of TUNEL-
positive cells presented as the mean 6 SD of three independent experiments. The lower panel shows ladder formation of nucleosome-length
fragments detected by LM–PCR, as described in Experimental Procedures.
(G) Expression of Mdm2 and p21Waf1 at 12 hr and p53R2 and Bax at 48 hr after UV radiation. Cell lysates were analyzed by immunoblotting
using specific antibodies as described in Experimental Procedures.
(H) Induction of p53AIP1 gene at 48 hr and p21Waf1 gene at 12 hr after UV radiation in MCF-7 cells. RT–PCR analysis was performed as
described in Experimental Procedures.
(I) The upper panel shows representative photographs of MCF-7 cells in the TUNEL assay at 48 hr after UV radiation, and the lower panel
shows three representative cell cycle phase in FACS analysis at 36 hr after UV radiation.
Yellow: cells dying from apoptosis. Cell lysates were analyzed by immunoblotting with antibodies against p53 (DO-1), phospho-Ser-15, Ser-
20, and Ser-46 of p53. Coomassie brilliant blue staining (CBB) shows that the same amount of total protein was applied to each lane.
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cells in the G0/G1 phase from 10 J/m2 in a dose-depen- manner as seen in the infected H1299 cells (data not
shown). This result supports the notion that Ser-46dent manner, and it reached a peak at 15 J/m2 (Figure
5E). At higher doses, the G0/G1 cells decreased and phosphorylation of p53 might be indispensable for p53-
dependent apoptosis.the percentage of apoptotic cells increased (Figures 5E
and 5F). Apoptosis detected by DNA ladder formation,
TUNEL assay, and FACS analysis showed that UV
radiation induced apoptosis beyond 20 J/m2 (Figures 5F Substitution of Ser-46 Impairs the Ability of p53
and 5I). to Induce Apoptosis
Taken together, these results suggest that phosphory- To determine whether phosphorylation of Ser-46 is in-
lation of Ser-46 is uniquely correlated with the induction volved in p53-dependent apoptosis, we mutated Ser-
of apoptosis by p53 and thus may be involved in a 46 to Ala and examined the ability of p53S46A to induce
different mode of p53 activation when compared to apoptosis by microinjection into SAOS-2 cells (Figures
phosphorylation of Ser-15 or Ser-20. 7A and 7B) and transient transfection to H1299 cells
(Figures 7C and 7D). Recognition by the anti-p-S46 anti-
body was completely impaired in p53S46A-microin-Expression of p53AIP1 but Not p21Waf1 Correlates
jected cells (Figure 7A), although there was no differencewith Ser-46 Phosphorylation
between p53WT and p53S46A in the expression levelWe next studied the dose-dependent effect of UV radia-
of p53 (Figure 7A) or phosphorylation at Ser-15 (datation on the induction of p53 target genes (Figures 5G
not shown). In cells microinjected with wild-type p53,and 5H). Initiation of induction of p53, Mdm2, p21Waf1,
the percentage of TUNEL-positive cells was 55% (Figureand p53R2 paralleled that of phosphorylation of Ser-15
7B) and classic signs of apoptosis such as shrinkingbut not Ser-46 (Figure 5G). Importantly, UV radiation
cytoplasm and membrane blebbing were observed 36stimulated expression of p53AIP1 mRNA only at 20 J/m2
hr after microinjection. On the other hand, the percent-or higher (Figure 5H), a dose dependency that was strik-
age of TUNEL-positive cells in p53S46A-microinjectedingly similar to that of Ser-46 phosphorylation (Figures
cells was greatly decreased compared to p53WT (Figure5D and 5H). These data suggest that the site-specific
7B). The same series of microinjection experiments werephosphorylation of Ser-46 is linked with apoptosis
also carried out using H1299 cells, and similar resultsthrough induction of p53AIP1.
were observed (data not shown).Since overexpression of p53 by adenovirus-mediated
The effect of substitution at Ser-46 on apoptosis wasp53 gene transfer to cancer cells is known to induce
further examined in transiently transfected H1299 cellsapoptosis in multiple cancer cell lines, we analyzed
(Figures 7C and 7D). Cells were collected at 48 hr afterphosphorylation at Ser-46, induction of p53AIP1, and
transfection and TUNEL analysis was performed. Thereapoptosis in p53 null H1299 cells infected by a recombi-
was no difference in levels of p53WT and p53S46A pro-nant adenovirus expressing wild-type p53. We found
tein and phosphorylation of Ser-15 and Ser-20 (Figurethat although phosphorylation at Ser-15 could be de-
7C); however, the ability of p53S46A to induce apoptosistected immediately following p53 detection, phosphory-
was greatly decreased compared to p53WT (Figure 7D).lation at Ser-46 was apparent at only 12 hr (Figure 6A).
These data thus support the likelihood that phosphoryla-Induction of p21Waf1 mRNA also occurred at around the
tion of Ser-46 is involved in induction of p53-dependentsame time as when p53 became phosphorylated at Ser-
apoptosis.15, which was several hours earlier than induction of
p53AIP1 mRNA and phosphorylation at Ser-46. Apo-
ptotic cells appeared after phosphorylation at Ser-46
Substitution of Ser-46 Abrogates the Ability of p53and induction of p53AIP1a.
to Stimulate Transcription of p53AIP1 but NotWe subsequently examined whether different levels
Other p53 Target Genesof p53 expression could affect induction of p53AIP1,
We next asked whether phosphorylation of Ser-46 regu-phosphorylation of Ser-46, or apoptosis. H1299 cells
lates induction of p53 target genes, especially p53AIP1,were infected with Ad-p53 at MOIs ranging 5–200. En-
by transfecting constructs expressing p53WT, p53S46A,dogenous p21Waf1 was highly induced even at 5–10 MOI,
p53S46del, or p53S121F into H1299 cells (Figures 8Awhereas doses of Ad-p53 .40 MOI were required to
and 8B). Expression of p53, Mdm2, p21Waf1, p53R2, andinduce endogenous p53AIP1 mRNA (Figure 6B, middle)
Bax, and phosphorylation at Ser-15, Ser-20, and Ser-and p53AIP1 protein (Figure 6B, right). Western blots
46 were analyzed by immunoblotting at 24 hr after trans-indicated that only a high dose of Ad-p53 could phos-
fection (Figure 8A). We also examined induction ofphorylation at Ser-46 be detected, although phosphory-
p53AIP1, PIG3, NOXA (Oda et al. 2000), and p21Waf1lation at Ser-15 was detected even at low doses of
mRNA by RT–PCR (Figure 8B). In cells transiently trans-Ad-p53 (Figure 6B, left). Similarly, FACS analysis demon-
fected with p53S46A and p53S46del, there was no differ-strated that apoptosis could be induced only at a high
ence in the expression level of p53 or phosphorylationdose of Ad-p53 (Figure 6B, bottom).
of Ser-15 and Ser-20 among p53WT and mutants (FigureTo evaluate the role of Ser-46 phosphorylation in p53-
8A). In addition, the ability to induce expression ofdependent apoptosis, we also examined the relation-
Mdm2, p21Waf1, p53R2, PIG3, NOXA, and Bax was notship between Ser-46 phosphorylation and apoptosis in-
different among p53WT and Ser-46 mutants, whileduction in U87MG infected by Ad-p53. A glioma cell line
p53S121F lost its ability to induce p21Waf1, PIG3, andU87MG contains the wild-type p53 protein and is known
Mdm2 (Figures 8A and 8B). Ser-121 is located in theto be tolerant to Ad-p53-inducing apoptosis (Gomez-
DNA binding domain of p53, and p53S121F was reportedManzano et al., 1996). Infection of Ad-p53 could induce
to lose the ability to induce expression of both Mdm2neither apoptosis of U87MG cells nor Ser-46 phosphory-
and p21Waf1 (Saller et al., 1999), which was confirmed bylation of p53, although the expression of p53 protein
was strikingly induced in a time- and a dose-dependent our results. Interestingly, the ability to stimulate mRNA
Cell
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Figure 6. Correlation among Phosphorylation at Ser-46 of p53, p53AIP1 Induction, and Apoptosis in Ad-p53-Inducing Apoptosis
(A) Time course of p53AIP1 induction, phosphorylation at Ser-46 of p53, and apoptosis by exogenous expression of p53 in H1299 cells. Cells
(6 3 105) were infected with Ad-p53 at a MOI of 80 for the indicated time periods in H1299 cells. Results of RT–PCR, Western blotting, and
FACS analyses are presented. Cells were harvested for the indicated time periods and lysate from each sample was resolved by 12%
SDS–PAGE, followed by immunoblotting with anti-p53 (Ab-6), anti-p53-P-Ser-15, or anti-p53-P-Ser-46 antibodies.
(B) Dose dependency of p53AIP1 induction, phosphorylation at Ser-46 of p53, and apoptosis by exogenous expression of p53 in H1299 cells.
H1299 cells were infected with Ad-p53 at the indicated MOI. H1299 cells were collected 21 hr (for Western blotting), 24 hr (RT–PCR analysis),
and 48 hr (FACS analysis) after infection. Results of RT–PCR, Western blotting, and FACS analyses are presented. Cells were harvested at
21 hr, and lysate from each sample was resolved by SDS–PAGE, followed by immunoblotting with anti-p53AIP1, anti-p53 (Ab-6), anti-p53-P-
Ser-15, or anti-p53-P-Ser-46 antibodies.
expression of p53AIP1 was greatly impaired in S46 mu- was performed using a synthetic reporter construct con-
tants (Figure 8B). These results indicate that phosphory- taining the p53AIP1-derived p53-responsive element
lation of Ser-46 regulates induction of p53AIP1 expres- upstream of the luciferase reporter, as described pre-
sion specifically. viously (Tanaka et al., 2000). p53AIP1 and p21Waf1 re-
Since the expression level of p53 is mainly regulated porter constructs were transiently transfected into
by protein degradation, we examined whether phosphy- SAOS-2 cells along with either p53WT or p53S46A ex-
lation of Ser-46 changes the half-life of p53 protein or pression plasmids. As shown in Figure 8C, transactiva-
not. p53WT and p53S46A expression plasmids were tion of p53AIP1 by p53S46A was significantly lower
transiently transfected into H1299 cells and a pulse- when compared to p53WT, although there was no differ-
chase experiment was performed. One set of cells was ence in p21Waf1 transactivation. We further performed
treated with IR (30 Gy) at 18 hr after transfection to EMSA experiments using nuclear extracts isolated from
examine prolongation of half-life after DNA damage. H1299 cells, which were transfected with either wild-
Both p53WT and p53S46A had similar half lives of about type p53 or mutant p53 (S46A) expression vector. As
z85 min in our system (data not shown), consistent with shown in Figure 8D, binding activity of the mutant p53
the fact that their expression levels as determined by (S46A) protein to p53AIP1-BDS but not to p21WAF1-
immunoblotting were almost equal among p53WT and BDS was impaired. These data suggest residue S46
mutants (Figure 8A). Moreover, IR stabilized and pro- on p53 regulates promoter selectivity through altered
longed the half-life of both versions of p53 (data not sequence-specific DNA binding.
shown), consistent with the fact that there was no differ-
ence in phosphorylation of Ser-15 and Ser-20 between
Discussionp53WT and S46A (Figure 8A).
Apoptosis and cell cycle arrest are the major tumorPhosphorylation of Ser-46 Regulates p53
suppression functions of p53. Induction of exogenousTranscriptional Activation and Binding
wild-type p53 causes apoptosis in not all but some p53-to the p53AIP1 p53 Response Element
mutated cancer cells (Levine, 1997). Several p53 targetTo determine if phosphorylation of Ser-46 regulates
transcriptional activation of p53AIP1, a reporter assay gene(s), including BAX and PIG, have been suggested as
Apoptosis Regulation by p53AIP1 and Ser-46 of p53
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Figure 7. Phosphorylation of Ser-46 Is Re-
quired for p53-Dependent Apoptosis in
SAOS-2 and H1299 Cells
(A) Expression of p53WT and p53S46A by mi-
croinjection of their expression plasmids into
SAOS-2 cells. Either p53WT or p53S46A ex-
pression plasmid was microinjected into the
nuclei of SAOS-2 cells. Cells were immunola-
beled with the specific antibodies against p53
(DO-1) (FITC conjugated) or phosphorylated
Ser-46 of p53 (rhodamine conjugated). The
nuclei of SAOS-2 cells were visualized by
DAPI staining.
(B) Apoptosis of SAOS-2 cells after microin-
jection of p53WT and p53S46A expression
plasmids. Apoptosis was analyzed by the
percentage of TUNEL-positive cells (yellow
cells) in microinjected cells. Data is presented
as the mean 6 SD of three independent ex-
periments.
(C) Expression and phosphorylation of p53 at
Ser-15, Ser-20, and Ser-46 in H1299 cells that
were transiently transfected with p53WT and
p53S46A expression plasmids. Cells were
collected at 18 hr after transfection and ana-
lyzed by immunoblotting with specific anti-
bodies against p53(DO-1), phospho-Ser-15,
Ser-20, and Ser-46 of p53, and b-actin.
(D) Apoptosis of H1299 cells transiently trans-
fected with p53WT and p53S46A expression
plasmids. Cells were collected at 48 hr after
transfection and analyzed by TUNEL assay.
The percentage of TUNEL-positive cells
among p53-positve cells is presented as the
mean 6 SD of three independent experi-
ments.
candidates for mediating this p53-dependent apoptotic mitochondria (Li et al., 1999). Hence, we speculate that
Bax may initiate apoptosis by a pathway distinct frompathway (Miyashita and Reed, 1995; Polyak et al., 1997).
We have demonstrated here that p53AIP1 is also a p53AIP1, but since Bcl-2 can inhibit the disruption of
DCm that is induced by p53 (Kroemer, 1997; Li et al.,strong candidate for this function. In contrast to other
candidate genes, p53AIP1 was isolated as a novel gene 1999), Bcl-2 may also interact with p53AIP1.
Our data strongly suggest that phosphorylation ofby cloning “functional” p53 binding sites (p53-tagged
sites) from human genomic DNA. This gene is not nor- Ser-46 is important in regulating the ability of p53 to
induce apoptosis. After obtaining these data, we notedmally expressed in any tissues except thymus, but it is
strongly inducible by DNA damage in a p53-dependent that several missense mutations near Ser-46 in p53 have
been reported in human cancers: Ser-46 to Phe in amanner, suggesting that its expression is strictly con-
trolled by p53 protein under specific conditions. bladder cancer (Ramchurren et al., 1995), Pro-47 to Leu
and Ser in a lung cancer and leukemia/lymphoma, re-Mitochondria play a key role in the regulation of apo-
ptosis because disruption of the mitochondrial mem- spectively (Mitsudomi et al., 1992; Yeargin et al., 1993).
These mutations may well impair phosphorylation ofbrane potential DCm constitutes a critical step in the
p53-dependent apoptotic pathway (Kroemer, 1997; Li Ser-46 and thus support our conclusions about the sig-
nificance of phosphorylation of this residue.et al., 1999). Our immunofluorescence data revealed that
p53AIP1 is located in mitochondria and that overexpres- We have shown that induction of p53AIP1 by DNA-
damaging agents such as adriamycin and g irradiationsion of the p53AIP1 gene causes dissipation of mito-
chondrial DCm. TUNEL and FACS analyses demon- was delayed significantly compared to induction of
p21WAF1. The latter occurred immediately after p53 induc-strated that transfection of p53AIP1 or infection with
Ad-p53AIP1 induces massive apoptotic cell death in tion, but p53AIP1 was induced only 6–12 hr later. This
time difference was puzzling, given that both genes areT98G cells, suggesting that p53AIP1 might mediate apo-
ptosis by regulation of mitochondrial DCm. Moreover, direct targets for p53. To explain this dichotomy, we
hypothesize that posttranslational modification of p53inhibition of p53AIP1 induction by an antisense oligonu-
cleotide strikingly blocked Ad-p53-induced apoptosis. protein might determine its affinity for specific p53
binding sequences present in different target genes andThe Bax gene product, which is involved in apoptosis,
is also upregulated by p53 (Miyashita and Reed, 1995). that the status of p53 modification soon after DNA dam-
age might be quite different from that in a later phase.This protein translocates from the cytosol to mitochon-
dria during apoptosis and induces release of cyto- This is supported by our observation that binding to
the p53AIP1 site is affected specifically by mutation ofchrome c, and Bax release can be inhibited by Bcl-2
(Green and Reed, 1998). However, p53-induced apo- Ser-46.
In summary, we propose the model shown in Figuresptosis is unlikely to depend on cytochrome c release
but rather on alteration of the membrane potential of 8E and 8F. In the early stage of p53 activation after DNA
Cell
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Figure 8. Phosphorylation of Ser-46 Is Needed for Induction of p53AIP1 but Not p21Waf1 or Others
(A) Expression and phosphorylation of p53 at Ser-15, Ser-20, and Ser-46 and induction of p53 target proteins in H1299 cells. Expression plasmids
of p53WT, p53S46A, p53S46del, and p53S121F were transiently transfected into H1299 cells. Cell lysates were analyzed by immunoblotting with
specific antibodies against p53, phospho-Ser-15, Ser-20, and Ser-46 of p53, Mdm2, p21Waf1, p53R2, and Bax in H1299 cells after transient
transfection. Cell lysates were analyzed by immunoblotting, as described in Experimental Procedures.
(B) Induction of the p53AIP1, PIG3, NOXA, and p21Waf1 genes in H1299 cells after transient transfection. RT–PCR analysis was performed as
described in Experimental Procedures.
(C) Phosphorylation of Ser-46 affects transcriptional activation of the p53AIP1 gene promoter. Activities of p53WT and p53S46A to transactivate
p21Waf1 and p53AIP1 promoters (upstream of the luciferase reporter) were compared in SAOS-2 cells using transient transfection. Activity is
represented as a relative value of measured luminescence from firefly luciferase versus Renilla luciferase from c-transfected pRL-TK (internal
control). Mean values of the results of three experiments are displayed with error bars of standard deviation.
(D) Impaired binding activity of the mutant p53 (S46A) protein to p53BDS of p53AIP1 but not p21Waf1. Nuclear extracts from H1299 cells
transfected with either wild-type p53 (WT) or S46A mutant-p53 (S46A) were used. EMSA assay was performed to examine the binding activity
of WT (wild-type) or S46A (mutant) p53 protein to p53BDS of p53AIP1 or p21Waf1.
(E) Phosphorylation of p53 at Ser-46 specifically transactivates apoptosis genes such as p53AIP1 but not p21Waf1 nor p53R2.
(F) Severely damaged DNA induces phosphorylation of Ser-46 for apoptosis mediation.
damage, phosphorylation of Ser-15, Ser-20, and some repair genes (p53R2 et al.), and other genes, such as
Mdm2. However, if DNA damage is severe and repair isother sites occurs, which in turn promotes binding of
p53 to promoters of G1 arrest genes (p21Waf1 et al.), DNA impossible, Ser-46 kinase is activated, leading to phos-
Apoptosis Regulation by p53AIP1 and Ser-46 of p53
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Hemagglutinin (HA) epitope tag was placed at the N terminusphorylation of Ser-46, a subtle change of p53 confor-
(pCAGGS/N-HA-p53AIP1-a, b, and g) or C terminus (pCAGGS/mation and a stronger affinity to promoters of apoptosis-
C-HA-p53AIP1-a, b, and g) of each expression vectors. The con-related genes, such as p53AIP1, compared to promoters
structs were confirmed by sequencing. pC53-SN3, expressing wild-of G1 arrest or DNA repair–related genes.
type human p53 from a cytomegalovirus (CMV) promoter, was ob-Alteration of affinities of p53 to different promoters
tained from Kaoru Segawa (Baker et al., 1990). p53-S46A, expressing
by subtle conformation change is suggested by other human p53 with codon 46 (serine) changed alanine, p53-S46del with
studies. For instance, tumor-derived p53 mutants that codon 46 (serine) deleted, and p53-S121F with codon 121 (serine)
have single amino acid substitutions in the DNA binding changed to phenylalanine were derived from pC53-SN3 by site-
domain, can induce p21Waf1 but cannot induce apoptosis directed mutagenesis. In brief, the QuikChange Site-Directed Muta-
at high temperatures (Friedlander et al., 1996; Ryan and genesis Kit (Stratagene) was used according to the manufacturer’s
instructions with the oligonucleotides 59-GATTTGATGCTGGCCCCVousden, 1998). In contrast, Ser-121Phe mutant was
GGACGATATTG-39 and 59-CAATATCGTCCGGGGCCAGCATCAAreported to be increased in apoptosis induction (Saller
ATC-39 to introduce a single nucleotide change in codon 46 serineet al., 1999). However, in our experiments, this mutant
of human p53 to alanine, 59-ATGGATGATTTGATGCTGCCGGACGAreduces induction of p21Waf1 and Mdm2 without chang-
TATTGAACAA-39 and 59-TTGTTCAATATCGTCCGGCAGCATCAAATing the induction level of p53AIP1 (Figures 8A and 8B).
CATCCAT-39 to delete codon 46 serine of human p53 to alanineThe properties of this mutant also support a correlation
59-GGGACAGCCAAGTTTGTGACTTGCACG-39 and 59-CGTGCAAGbetween apoptosis and p53AIP1 induction. A change
TCACAAACTTGGCTGTCCC-39 to introduce a single nucleotide
in selectivity among different p53 target promoters by change in codon 121 serine to phenylalanine. The presence of the
conformational change of p53 was also found by Res- changes was confirmed by DNA sequence analysis.
nick-Siverman et al. (1998). Furthermore, Wang and
Prives (1995) showed that DNA binding by p53 to differ- Cell Culture and Transfections
ent sites was selectively stimulated by phosphorylation Normal human fibroblast cell line NHDF4042, derived from neonatal
of Ser-315. skin, was purchased from Clonetics. H1299, A549 (human nonsmall
Apoptosis induction or p53AIP1 induction was not lung carcinoma), SW480 (colorectal adenocarcinoma), U373MG
(glioblastoma), SAOS-2 (human osteosarcoma), and MCF-7 (humancompletely abrogated by S46A substitution in our exper-
mammary carcinoma) cells were purchased from ATCC. T98G (glio-iments (Figures 7B, 7D, 8B, and 8C). One explanation
blastoma) was purchased from Human Science Research Resourcefor this is that there is an equilibrium between free p53
Bank (HSRRB, Japan). All cells were cultured under conditions rec-and p53 bound to promoters in cells. In addition, it is
ommended by their respective depositors. For transfection, cellslikely that the S46A mutant has a weak affinity for pro-
were seeded at 2 3 105 cells per multiwell six culture plate andmoters of apoptosis-related genes compared to WT-
transfected with 1 mg of plasmid mixtures preincubated for 30 minp53 phosphorylated at Ser-46. Thus, if p53S46A is ex-
with 5 ml of lipofectamine 2000 reagents (GIBCO–BRL).
pressed at a high level using the strong CMV vector,
some mutant p53 is likely to bind to promoters of apo-
Semiquantitative RT–PCR Analysis
ptosis-related genes. Moreover, in transfection or micro- Isolation of total RNA from cells was performed using RNeasy spin
injection of plasmids, the promoter structure is shown column kits (QIAGEN) according to the manufacturer’s instructions.
to be different from endogenous promoters that form cDNAs were synthesized from 10 mg total RNAs with SuperScript
natural chromatin structure (Kadonaga, 1998). There- Preamplification System (GIBCO–BRL). The RT–PCR exponential
fore, it is possible that p53S46A binds to the p53AIP1 phase was determined on 15–30 cycles to allow semiquantitative
comparisons among cDNAs developed from identical reactions.BDS of the reporter plasmid more easily than to the
Each PCR regime involved a 948C, 2 min initial denaturation stependogenous p53AIP1 BDS (Figure 8C).
followed by 30 cycles (for p53AIP1), 19 cycles (for p21Waf1), and 15It was recently suggested, using indirect methods,
cycles (for GAPDH) at 948C for 30 s, 558C–578C for 30 s, and 728Cthat Ser-46 is phosphorylated by p38 MAP kinase (Bu-
for 1 min on a Gene Amp PCR system 9600 (Perkin Elmer). Primerlavin et al., 1999). We have observed, however, that
sequences for p53AIP1 were designed to amplify p53AIP1-a tran-phosphorylation of Ser-46 after DNA damage is not in-
script (nucleotide 137–550). The PCR products were separated byhibited by SB202190 and SB203580, which are potent
electrophoresis on 2.5% agarose gels.inhibitors of p38 MAP kinase (data not shown). More-
over, we have been unable to demonstrate that purified
DNA Damage Treatments
p38 MAP kinase phosphorylates GST-p53 at Ser-46 in Cells were seeded 24 hr prior to treatment and were 60%–70%
vitro (data not shown). Furthermore, Sanchez-Pieto et confluent at the time of treatment. To examine the expression of
al. (2000) compared in vitro phosphorylation of GST-p53 p53AIP1 in response to genotoxic stresses, NHDF and SW480 cells
(1–86) WT, S33A, and S46A by p38 MAP kinase and were continuously treated with adriamycin (doxorubicin) at a con-
observed that S46A can be phosphorylated almost to centration of 0.2 mg/ml or irradiated (14 Gy) at z1 Gy/min. To analyze
the same level as WT, whereas S33A is not phosphory- phosphorylation of p53, cells were treated with adriamycin (doxoru-
bicin) at a concentration of 3 mM or treated with UV at indicatedlated by this kinase. Thus, we do not believe that p38
dosage (J/m2) using a UV cross-linker (Stratagene) or irradiated byMAP kinase is likely to be the Ser-46 kinase. We have
g ray at the indicated dosage using a 60Co source.recently observed induction of a Ser-46 kinase activity
after DNA damage of cells (data not shown). Purification
Microinjectionand identification of this kinase should provide new in-
Cells were plated at 50% density on glass coverslips and allowedsights into the intracellular signaling pathways involved
to adhere overnight. Before microinjection, HEPES buffer was addedin p53-mediated apoptosis.
to the medium at 40 mM of the final concentration. Wild-type and
mutant p53 expression plasmids at 1 mg/ml were then microinjectedExperimental Procedures
into the nuclei of cells using an Eppendorf microinjector and micro-
manipulator. After 36 hr, cells were fixed in 4% paraformaldehydePlasmids
for 1 hr and TUNEL assay was performed.The entire coding sequence of cDNAs (p53AIP1-a, b, and g) were
amplified by PCR using pfu DNA polymerase (Stratagene) and in-
Immunocytochemistryserted into the unique EcoRI site of the pCAGGS mammalian expres-
Transiently transfected COS-7 cells with pCAGGS/N-HA-p53AIP1-asion vector, which contains a CAG (cytomegalovirus immediate-
early enhancer chicken b-actin hybrid) promoter (Niwa et al., 1991). were replated on poly-D-lysine-coated multiwell chamber slides
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(Beckton Dickinson). Then the cells were fixed with 4% paraformal- Immunoblot Blot Analysis and Antibodies
For preparation of whole-cell lysates, adherent and detached cellsdehyde in PBS and permeabilized with 0.1% Triton X-100 in PBS
for 3 min at 48C. Cells were covered with blocking solution (3% were collected and resuspended in chilled lysis buffer: 50 mM
HEPES (pH 7.0), 2 mM MgCl2, 250 mM NaCl, 0.1 mM EDTA, 0.1 mMBSA in PBS) for 60 min at room temperature. Then the cells were
incubated with rat anti-HA antibody, 3F10 (Boehringer, diluted EGTA, 1 mM DTT, 2 mM Na3VO4, 10 mM Na4P2O7, 10 mM NaF, 0.1%
NP-40, 0.5 mM p-amidinophenyl methanesulfonyl fluoride hydro-1:1000 in blocking solution), and mouse anti-human mitochondria
antibody (Leinco Technologies, diluted 1:500 in blocking solution) chloride [p-APMSF], and a protease inhibitor cocktail consisting of
2.5 mg/ml pepstatin A, 2.5 mg/ml antipain, 2.5 mg/ml chymostatin,for 2 hr at room temperature. These antibodies, rat anti-HA antibody,
and mouse anti-human mitochondria antibody were stained with a 0.25 mg/ml leupeptin, and 0.25 mg/ml antipain. Collected cells were
allowed to lyse with sonication on ice. The homogenate was centri-goat anti-rat secondary antibody conjugated to FITC and a goat anti-
fuged for 5 min in a microcentrifuge at 48C and the supernatantsmouse secondary antibody conjugated to rhodamine, respectively,
were collected and boiled in SDS sample buffer. Each 50 mg ofand viewed with an ECLIPSE E600 microscope (Nikon).
SDS sample was loaded onto 10% and 12.5% SDS–PAGE gelsTo perform phospho-Ser-46 immunostaining of p53 in cells mi-
and blotted onto PVDF membranes (Amersham Pharmacia Biotech).croinjected with either wild-type p53 or mutant p53 (S46A) at 18 hr
Anti-p21Waf1 antibody was purchased from Transduction Labora-after microinjection, cells were fixed in 4% paraformaldehyde and
tories. Anti-mdm2 antibody (Ab-1) and anti-p53 antibodies (DO-1,permealized with 0.1% Triton X-100 in PBS for 3 min at 48C. Cells
Pab421, and Pab1801) were purchased from Oncogene Researchwere incubated with blocking solution containing 3% BSA in PBS for
Products. Anti-p-Ser-15 and Ser-20 of p53 antibody were described60 min at room temperature. Subsequently, the cells were incubated
previously (Shieh et al., 1997, 1999). A similar approach was usedwith anti-p53 monoclonal antibody DO-1 (diluted 1:100 in blocking
for generating the anti-p-Ser-46 polyclonal antibody. In this case, thesolution) and anti-phospho-Ser-46 of p53 rabbit polyclonal antibody
phosphorylated peptide MDDLMLS(PO3H2)PDDIEQC (amino acids(diluted 1: 50) for 2 hr at room temperature. The primary antibodies
40–52) was used for immunization of rabbits. These phospho-spe-were stained with a goat anti-mouse secondary antibody conjugated
cific antibodies were subsequently purified through antigen affinityto FITC and a goat anti-rabbit secondary antibody conjugated to
columns. Polyclonal antibodies against p53AIP1 protein were gener-rhodamine (diluted 1: 1000) for 1 hr and viewed with an ECLIPSE
ated in rabbits using a synthetic peptide of C termini of p53AIP1.E600 microscope (Nikon).
Protein bands in Western blotting were visualized by chemilumines-To assess the mitochondrial membrane potential, cells were incu-
cent detection (ECL) (Amersham).bated with the medium containing 70 mM MitoTracker Red CMXRos
(Molecular Probes) for 30 min at 378C before fixation to be labeled
Antisense Oligonucleotideswith a longer wavelength (579–599 nm) fluorescence emission.
To inhibit expression of endogenous p53AIP1, we prepared HPLC-
purified antisense oligonucleotide (AS1: GATCCCATCCAGGGGA)
and, as a control, sense oligonucleotide (SE1: GGAGGCAGGTGAGDetection of Apoptosis
GAG) according to the sequence of the p53AIP1 gene. FITC-labeledApoptosis was detected by FACS, TUNEL assay, and DNA ladder
AS was used for evaluation of nuclear incorporation efficiency. Anti-assay by LM–PCR. For FACS analysis, 36 hr after DNA damage,
sense oligonucleotides (1 mM) were transfected with Lipofectin re-adherent and detached cells were combined and fixed overnight
agent (GIBCO–BRL) for 4 hr and then cells were infected with eitherwith 75% ethanol in PBS at 48C. After rinsing two times with PBS,
Ad-p53 or Ad-LacZ. Forty-eight hours after infection, apoptotic cellscells were incubated for 30 min with 1 ml of PBS containing 1 mg
were analyzed by FACS analysis.of boiled RNase at 378C. Cells were then stained in 1 ml of PBS
containing 10 mg of propidium iodide. A total of 2 3 104 cells were
then analyzed in a flow cytometer (FACScalibur; Becton Dickinson). EMSA Experiment
In situ terminal transferase-mediated dUTP nick end labeling EMSA was performed as previously described (Tanaka et al., 2000),
(TUNEL) was performed using Apoptag Direct (INTERGEN) as sug- using oligonucleotides corresponding to the binding site of the
gested by the manufacturers. T98G cells were transfected with ei- p53AIP1 gene and GTCAGGAACATGTCCCAACATGTTGAGCTC of
ther p53AIP1 expression vector (pCAGGS/N-HA-p53AIP1-a) or a p21Waf1 promoter.
p53 expression vector (wild-type or mutant) as described above. In
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